US Markets

Henlius Biotech launches $477 mln HK IPO, to test market amid protests

Shanghai Henlius Biotech, backed by Chinese conglomerate Fosun International, launched on Wednesday its Hong Kong IPO of up to $477 million, a term-sheet showed, the first sizeable float to test market sentiment amid the city's political unrest.

By Julie Zhu

HONG KONG, Sept 11 (Reuters) - Shanghai Henlius Biotech, backed by Chinese conglomerate Fosun International 0656.HK, launched on Wednesday its Hong Kong IPO of up to $477 million, a term-sheet showed, the first sizeable float to test market sentiment amid the city's political unrest.

The company, which started gauging investor demand on Aug. 26, is selling 12% of its enlarged share capital in the initial public offering at a price range of HK$49.6 to HK$57.8 ($6.33-$7.37), according to the term sheet seen by Reuters.

The price range represents a valuation of about $3 billion-$3.5 billion prior to the float, versus $3 billion in a pre-IPO fundraising in November 2018.

Henlius has also lined up a total of $140 million from four cornerstone investors. Qatar Investment Authority has made the biggest commitment of $90 million, the term-sheet shows.

The float will be a key gauge of investor appetite after China's Alibaba Group Holding Ltd BABA.N last month delayed plans for a $15 billion listing amid the city's political turmoil.

Henlius, a developer of innovative drugs and biosimilars - which are not exact replicas but are as effective as the original drug, did not immediately respond to a request for comment.

($1 = 7.1049 Chinese yuan)

($1 = 7.8402 Hong Kong dollars)

(Reporting by Julie Zhu; Editing by Himani Sarkar)

((julie.zhu1@thomsonreuters.com; +852 2843 6519; Reuters Messaging: julie.zhu1.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More